IBDEI1II ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24470,1,2,0)
 ;;=2^90647
 ;;^UTILITY(U,$J,358.3,24470,1,3,0)
 ;;=3^HIB VACCINE, PRP-OMP, IM
 ;;^UTILITY(U,$J,358.3,24471,0)
 ;;=90648^^83^1070^17^^^^1
 ;;^UTILITY(U,$J,358.3,24471,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24471,1,2,0)
 ;;=2^90648
 ;;^UTILITY(U,$J,358.3,24471,1,3,0)
 ;;=3^HIB VACCINE, PRP-T, IM
 ;;^UTILITY(U,$J,358.3,24472,0)
 ;;=90649^^83^1070^10^^^^1
 ;;^UTILITY(U,$J,358.3,24472,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24472,1,2,0)
 ;;=2^90649
 ;;^UTILITY(U,$J,358.3,24472,1,3,0)
 ;;=3^H PAPILLOMA VACC 3 DOSE IM
 ;;^UTILITY(U,$J,358.3,24473,0)
 ;;=90675^^83^1070^26^^^^1
 ;;^UTILITY(U,$J,358.3,24473,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24473,1,2,0)
 ;;=2^90675
 ;;^UTILITY(U,$J,358.3,24473,1,3,0)
 ;;=3^RABIES VACCINE, IM
 ;;^UTILITY(U,$J,358.3,24474,0)
 ;;=90676^^83^1070^25^^^^1
 ;;^UTILITY(U,$J,358.3,24474,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24474,1,2,0)
 ;;=2^90676
 ;;^UTILITY(U,$J,358.3,24474,1,3,0)
 ;;=3^RABIES VACCINE, ID
 ;;^UTILITY(U,$J,358.3,24475,0)
 ;;=90680^^83^1070^27^^^^1
 ;;^UTILITY(U,$J,358.3,24475,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24475,1,2,0)
 ;;=2^90680
 ;;^UTILITY(U,$J,358.3,24475,1,3,0)
 ;;=3^ROTAVIRUS VACC 3 DOSE, ORAL
 ;;^UTILITY(U,$J,358.3,24476,0)
 ;;=90698^^83^1070^3^^^^1
 ;;^UTILITY(U,$J,358.3,24476,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24476,1,2,0)
 ;;=2^90698
 ;;^UTILITY(U,$J,358.3,24476,1,3,0)
 ;;=3^DTAP-HIB-IPV VACCINE, IM
 ;;^UTILITY(U,$J,358.3,24477,0)
 ;;=90707^^83^1070^21^^^^1
 ;;^UTILITY(U,$J,358.3,24477,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24477,1,2,0)
 ;;=2^90707
 ;;^UTILITY(U,$J,358.3,24477,1,3,0)
 ;;=3^MMR VACCINE, SC
 ;;^UTILITY(U,$J,358.3,24478,0)
 ;;=90710^^83^1070^22^^^^1
 ;;^UTILITY(U,$J,358.3,24478,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24478,1,2,0)
 ;;=2^90710
 ;;^UTILITY(U,$J,358.3,24478,1,3,0)
 ;;=3^MMRV VACCINE, SC
 ;;^UTILITY(U,$J,358.3,24479,0)
 ;;=90713^^83^1070^23^^^^1
 ;;^UTILITY(U,$J,358.3,24479,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24479,1,2,0)
 ;;=2^90713
 ;;^UTILITY(U,$J,358.3,24479,1,3,0)
 ;;=3^POLIOVIRUS, IPV, SC/IM
 ;;^UTILITY(U,$J,358.3,24480,0)
 ;;=90714^^83^1070^28^^^^1
 ;;^UTILITY(U,$J,358.3,24480,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24480,1,2,0)
 ;;=2^90714
 ;;^UTILITY(U,$J,358.3,24480,1,3,0)
 ;;=3^TD VACCINE NO PRSRV  IM
 ;;^UTILITY(U,$J,358.3,24481,0)
 ;;=90723^^83^1070^2^^^^1
 ;;^UTILITY(U,$J,358.3,24481,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24481,1,2,0)
 ;;=2^90723
 ;;^UTILITY(U,$J,358.3,24481,1,3,0)
 ;;=3^DTAP-HEP B-IPV VACCINE, IM
 ;;^UTILITY(U,$J,358.3,24482,0)
 ;;=90734^^83^1070^19^^^^1
 ;;^UTILITY(U,$J,358.3,24482,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24482,1,2,0)
 ;;=2^90734
 ;;^UTILITY(U,$J,358.3,24482,1,3,0)
 ;;=3^MENINGOCOCCAL VACCINE, IM
 ;;^UTILITY(U,$J,358.3,24483,0)
 ;;=90733^^83^1070^20^^^^1
 ;;^UTILITY(U,$J,358.3,24483,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24483,1,2,0)
 ;;=2^90733
 ;;^UTILITY(U,$J,358.3,24483,1,3,0)
 ;;=3^MENINGOCOCCAL VACCINE, SC
 ;;^UTILITY(U,$J,358.3,24484,0)
 ;;=90736^^83^1070^29^^^^1
 ;;^UTILITY(U,$J,358.3,24484,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24484,1,2,0)
 ;;=2^90736
 ;;^UTILITY(U,$J,358.3,24484,1,3,0)
 ;;=3^ZOSTER (SHINGLES) VACCINE,LIVE,SUBCUT
 ;;^UTILITY(U,$J,358.3,24485,0)
 ;;=90746^^83^1070^13^^^^1
 ;;^UTILITY(U,$J,358.3,24485,1,0)
 ;;=^358.31IA^3^2
